Adalimumab: procurement and reference pricing FAQ

See below for an FAQ document produced through the RMOC system on adalimumab. It includes detail on the procurement process, its outcome and implementation.

AdalimumabBiosimilar medicineRMOC medicines optimisation recommendations and resources

Attachments